RTXs Javelin Joint Venture Completes First Delivery of NextGeneration LWCLU System Signos Secures 20M Funding to Expand AI Health Tracking Amid GLP1 Weight Loss Boom Mphasis and Glenmark Among Jay Thakkars ShortTerm FO Picks Amid Market Caution Charter Communications and Liberty Broadband Buyout Deal Announced at Enhanced Terms Legal Case Dismissal for Kilmar Abrego Garcia Could Signal Shift in Immigration Enforcement Dynamics Embecta EMBC Faces Target Price Cut Amid Weakening Medtech Sentiment Deere Q1 2026 Earnings Strong EPS Beat Amidst Weak Agricultural Demand REAL Q1 2026 Earnings Narrowing Losses as Consignment Volumes Improve American Realty Investors Inc Q3 2024 Earnings Negative EPS of 108 as Losses Persist Stock Declines Janus Living Q1 2026 Earnings EPS Falls Short of Analyst Expectations PERI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter BDSX Q1 2026 Earnings EPS Surprises to the Upside Amid Operational Progress Serina Therapeutics SER Faces Selling Pressure Tests Key Support Levels Interlink Electronics LINK Dips 33 as Stock Tests Key Support Levels Avis Budget Group CAR Edges Lower as Shares Test Key Support Levels XOMAO Preferred Shares Hold Steady Near 2532 as Yield Hunters Await Catalysts Banco Latinoamericano BLX Holds Steady Near Midpoint as Support and Resistance Define Range Nvidia Data Center Revenue Nearly Doubles Stock Slips Despite Strong Earnings Ballard Power Systems BLDP Q1 2026 Earnings Narrowing Loss Beats Estimates Shares Edge Higher Allspring MultiSector Income Fund ERC Holds Near Support as FixedIncome Markets Eye Rate Signals Public Policy Holding Company Inc PPHC Q4 2025 Earnings EPS Surges Past Estimates Stock Eases Lower Skillz Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remains Withheld Six Flags Entertainment Q1 2026 Earnings Narrowerthanexpected loss amid seasonal headwinds NOTE Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Headwinds Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech Minerva Neurosciences Inc NERV Q1 2026 Earnings Wider Loss Highlights Ongoing PreRevenue Development Stage MODD Q3 2025 Earnings EPS Misses Expectations Stock Gains 89